Participants and study assessments Forty-two free living healthy individuals were recruited from the region of Southwestern Ontario, Canada
Semaglutide injection or oral dosing should not interfere if spacing is maintained, but discuss exact timing with your healthcare team to avoid any absorption issues
Minimize foods with ingredients that rapidly deplete glutathione stores: NO ultra-processed foods, no refined sugar, no toxins such as preservatives, dyes, additives
Building Sustainable Habits One of the most important lessons for anyone using GLP-1 medications is that long-term success usually comes from sustainable habits rather than extreme approaches
Routine discussion at your next scheduled appointment is appropriate for mild injection site reactions that resolve within a few days, minor itching without rash that is intermittent and tolerable, or gradual skin texture changes that may be related to weight loss
Orforglipron Orforglipron (Eli Lilly) is a novel oral GLP-1 receptor agonist that is currently in phase 3 clinical trials
